EIF3F
protein-codingeukaryotic translation initiation factor 3 subunit F, the group of Eukaryotic translation initiation factor 3|JAMM/MPN+ metallopeptidase family
Gene summary
Enables identical protein binding activity and metal-dependent deubiquitinase activity. Contributes to translation initiation factor activity. Involved in IRES-dependent viral translational initiation and translational initiation. Located in membrane. Part of eukaryotic translation initiation factor 3 complex. Implicated in autosomal recessive intellectual developmental disorder 67. [provided by Alliance of Genome Resources, Jul 2025]
- EIF3S5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~31.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0032662
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0000508
Submitter: ClinGen
*EIF3F* was first reported in relation to autosomal recessive syndromic intellectual disability in 2018 (Martin et al., PMID: 30409806). *EIF3F* encodes an essential subunit of eIF3, the largest eukaryotic translation initiation factor, which plays a role in cell proliferation and growth, cell cycle control, differentiation, and apoptosis. At least 31 patients from 24 families have been reported with biallelic *EIF3F* variants; 30 of these patients were homozygous for the same p.Phe232Val missense variant, and 1 patient was compound heterozygous for the p.Phe232Val missense variant and a frameshift variant (PMIDs: 30409806, 33736665). Haplotype analyses suggested that p.Phe232Val is a founder variant (PMID: 33736665). The p.Phe232Val variant has a frequency of 0.16% in non-Finnish Europeans, and no homozygotes are observed in gnomAD (v4.0.0). The mechanism of pathogenicity appears to be loss of function. Affected individuals present with global developmental delay, motor and speech delays, and intellectual disability; variable features include hearing loss, dysmorphic facial features, abnormal behaviors, hypo- or hypertonia, ophthalmological abnormalities, and epilepsy (PMIDs: 30409806, 33736665). Induced pluripotent stem cells (iPSC) homozygous for the p.Phe232Val missense variant had ~27% lower EIF3F protein levels, and significantly reduced translation and proliferation rates compared to heterozygous and wild-type cells (PMID: 30409806). In summary, there is definitive evidence supporting the relationship between *EIF3F* and autosomal recessive syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 6, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0032662
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032662
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032662
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EIF3F variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003754.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 23 | 24 | |||
| missense | 2 | 54 | 6 | 1 | 63 | |
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 3 | 60 | 29 | 1 | 94 |
Highest pathogenic variant AF is 0.0012514931
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003745.1 | 8 | MANE Select | |
| Ensembl | ENSP00000499218.1 | 8 | MANE Select | |
| Ensembl | ENSP00000432489.2 | 4 | Standard | |
| Ensembl | ENSP00000434286.2 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| eif3f | Danio rerio | Structure: pharyngeal arch cartilage Quality: malformed abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RNA transport - Homo sapiens (human)
- Translation Factors
- Formation of the ternary complex, and subsequently, the 43S complex
- Translation initiation complex formation
- Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
Biological Process
- formation of cytoplasmic translation initiation complex
- translational initiation
- protein deubiquitination
- IRES-dependent viral translational initiation
Molecular Function
- translation initiation factor activity
- thiol-dependent ubiquitin-specific protease activity
- protein binding
- translation initiation factor binding
Cellular Component
- cytosol
- eukaryotic translation initiation factor 3 complex
- membrane
- eukaryotic 43S preinitiation complex
- eukaryotic 48S preinitiation complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000533626
- Coding exons
- 8
- Length
- 31612
- Individuals with no LoFs
- 125747
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125748
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.108 | 212 | 208 | 1.02 | 0.0000109 | 2268 |
| Missense (PolyPhen) | 31 | 48.671 | 0.63692 | 632 | ||
| Synonymous | -2.24 | 113 | 86.5 | 1.31 | 0.00000503 | 768 |
| Loss of Function | 3.39 | 1 | 15.3 | 0.0654 | 7.38e-7 | 181 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre- initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF- 3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03005, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.435
- RVIS EVS
- -0.29
- RVIS percentile EVS
- 33.2
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.806
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |